Upgrade to SI Premium - Free Trial

CervoMed (CRVO)

2.44 +0.19 (8.44%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/17/26)

Latest Headlines

Form 4 CervoMed Inc. For: Jun 08 Filed by: ZAVRL FRANK June 10, 2026 7:45 PM - SEC Filing Form 4 CervoMed Inc. For: Jun 08 Filed by: Sabbagh Marwan June 10, 2026 7:45 PM - SEC Filing Form 4 CervoMed Inc. For: Jun 08 Filed by: Quigley David June 10, 2026 7:44 PM - SEC Filing Form 4 CervoMed Inc. For: Jun 08 Filed by: Poulton Jeffrey V. June 10, 2026 7:44 PM - SEC Filing Form 4 CervoMed Inc. For: Jun 08 Filed by: Hollingsworth Jane H June 10, 2026 7:43 PM - SEC Filing Form 4 CervoMed Inc. For: Jun 08 Filed by: Gregoire Sylvie June 10, 2026 7:43 PM - SEC Filing Form 4 CervoMed Inc. For: Jun 08 Filed by: BOGER JOSHUA S June 10, 2026 7:43 PM - SEC Filing Form 4 CervoMed Inc. For: Jun 08 Filed by: ALAM JOHN J June 10, 2026 7:42 PM - SEC Filing CervoMed (CRVO) PT Lowered to $15 at Brookline Capital Markets June 10, 2026 5:02 PM - StreetInsider Form 8-K CervoMed Inc. For: Jun 09 June 10, 2026 7:41 AM - SEC Filing CervoMed raises $10.5 million, seeks partnership for dementia drug June 10, 2026 7:30 AM - StreetInsider CervoMed Announces Private Placement Financing and Plan to Focus on Strategic Partnering to Advance Neflamapimod into Phase 3 for Dementia with Lewy Bodies June 10, 2026 7:30 AM - StreetInsider Form 8-K CervoMed Inc. For: Jun 08 June 9, 2026 6:06 AM - SEC Filing Form 8-K CervoMed Inc. For: May 18 May 18, 2026 4:58 PM - SEC Filing CervoMed Reports First Quarter 2026 Financial Results and Provides Corporate Updates May 18, 2026 7:30 AM - Globe NewsWire Form 10-Q CervoMed Inc. For: Mar 31 May 15, 2026 9:12 AM - SEC Filing Form SCHEDULE 13G/A CervoMed Inc. Filed by: MORGAN STANLEY May 11, 2026 1:41 PM - SEC Filing Form ARS CervoMed Inc. For: Dec 31 April 30, 2026 4:15 PM - SEC Filing Form DEF 14A CervoMed Inc. For: Jun 08 April 30, 2026 10:18 AM - SEC Filing Form 8-K CervoMed Inc. For: Apr 22 April 22, 2026 4:08 PM - SEC Filing CervoMed Announces New Data at the 2026 AAN Annual Meeting that Demonstrated Neflamapimod Increased Basal Forebrain Volume and Functional Connectivity in Dementia with Lewy Bodies April 22, 2026 7:30 AM - Globe NewsWire Form SCHEDULE 13G/A CervoMed Inc. Filed by: AWM Investment Company, Inc. April 7, 2026 4:25 PM - SEC Filing Form 8-K CervoMed Inc. For: Apr 07 April 7, 2026 4:07 PM - SEC Filing CervoMed to Provide Neflamapimod Clinical Program Update and Participate in a Panel on Biomarkers at 2026 Lewy Body Dementia Association Annual Meeting April 7, 2026 12:26 PM - Globe NewsWire CervoMed to Provide Neflamapimod Clinical Program Update and Participate in a Panel on Biomarkers at 2026 Lewy Body Dementia Association Annual Meeting April 7, 2026 7:30 AM - StreetInsider Jones Trading Assumes CervoMed (CRVO) at Buy April 6, 2026 4:16 PM - StreetInsider Form 8-K CervoMed Inc. For: Mar 23 March 23, 2026 4:06 PM - SEC Filing Form 8-K CervoMed Inc. For: Mar 19 March 19, 2026 4:41 PM - SEC Filing CervoMed shares new data showing drug benefits for dementia patients March 19, 2026 7:31 AM - StreetInsider CervoMed Announces New Data at the AD/PD™ 2026 Scientific Conference that Reinforce Neflamapimod’s Positive Effects in Dementia with Lewy Bodies (DLB) in Patients without Alzheimer’s Disease Co- March 19, 2026 7:30 AM - StreetInsider CervoMed (CRVO) PT Lowered to $11 at Roth/MKM March 18, 2026 8:05 AM - StreetInsider Form 8-K CervoMed Inc. For: Mar 17 March 17, 2026 4:34 PM - SEC Filing CervoMed Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Updates March 17, 2026 7:30 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on CervoMed (CRVO) March 17, 2026 6:48 AM - StreetInsider Form 10-K CervoMed Inc. For: Dec 31 March 13, 2026 5:02 PM - SEC Filing Full Article List